ABSTRACT
Objective To investigate the hospital acquired infections in the Traditional Chinese Medicine Division of Nanshan People's Hospital, Shenzhen so to improve the infection control. Method The hospital acquired infection cases in the Traditional Chinese Medicine division during the time from May 1,2006 to May 1, 2007 were reviewed. The risk factors of acquired infections in hospital for Ankylosing Spondylitis patients were analysed and summed up. Result The hospital infection rate was 5.1% (22/435), while the total hospital acquired infection rate in the hospital was 3.2% (957/29 846). Among the 22 patients, 6 cases were ankylosing spondylitis cases. The rate of hospital acquired infection in ankylosing spondylitis patients in the division was as high as 25.0% (6/24) in contrast to the rate of zero in other wards. Further analysis showed that taking cellulotoxic drugs was the main risk factor of hospital acquired infection in ankylosing spondylitis patients (P <0.01). Conclusion The patients treated with cellulotoxic drugs should be monitored for hospital acquired infection so as enhance the early control.
ABSTRACT
Objective To observe the clinical therapeutic effects of Chushihuayu Decoction on the level of serum uric acid and triglycerides in patients with hyperuricemia and hypertriglyceridemia. Methods Fifty cases of hyperuricemia and hypertriglyceridemia with damp-heat syndrome (DHS) were randomly divided into Chushihuayu Decoction-treated group and benzbromarone-treated group. The course of the treatment was 30 days. The serum levels of uric acid and triglycerides before and after treatment were analyzed. Results The serum level of uric acid was reduced in Chushihuayu Decoction-treated group. The DHS was relieved in Chushihuayu Decoction-treated group. The serum level of triglycerides was lowered in Chushihuayu Decoction-treated group. Conclusion Chushihuayu Decoction can decrease serum uric acid and triglycerides, and improve the DHS.
ABSTRACT
[Objective] To evaluate the effect and safety of bee-stinging therapy in treating undifferentiated connective tissue disease (UCTD). [Methods] Forty cases of UCTD were treated with bee-stinging therapy (qd or qod) for two treatment course, each course lasting 15 times. The symptoms of morning stiffness (MS), joint pain (JP) and articular swelling (AS), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) and side effects were observed before and after treatment. [Results] After treatment, clinical symptoms and ESR and CRP were significantly improved (P